Literature DB >> 6160004

Restrictions in the response to autologous thyroglobulin in the human.

L Nye, L C Pontes de Carvalho, I M Roitt.   

Abstract

Fragments of thyroglobulin containing the autoreactive epitopes were prepared by an existing procedure, plus an ion-exchange chromatography step which increased their purity. Before purification, 39% of the fragmental material was bound by rabbit anti-human thyroglobulin whereas only 8% was bound by autoantibody, thus confirming earlier reports of more limited epitopes for human autoantibodies than heterologous antibody. Thyroglobulin autoantibodies in the globulin fractions from six human sera showed between 70 and 100% cross-reaction with one another, indicating that the majority of antibodies are directed against the same epitopes. The data are consistent with an estimated of two distinct major epitopic specificities with occasional sera having antibodies directed against a third site. Chemical modification of tyrosine residues by iodination did not inhibit the binding of thyroglobulin to either human autoantibodies or rabbit anti-human thyroglobulin; thus tyrosine residues do not contribute significantly to the epitopes for either auto- or heteroantibodies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160004      PMCID: PMC1537003     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Endogenous proteolytic activity and constituent polypeptide chains of sheep and pig 19 S thyroglobulin.

Authors:  M Rolland; S Lissitzky
Journal:  Biochim Biophys Acta       Date:  1976-04-14

Review 2.  THE STRUCTURE OF THYROGLOBULIN AND ITS ROLE IN IODINATION.

Authors:  H EDELHOCH
Journal:  Recent Prog Horm Res       Date:  1965

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  The nature of the thyroid auto-antibodies present in patients with Hashimoto's thyroiditis (lymphadenoid goitre).

Authors:  I M ROITT; P N CAMPBELL; D DONIACH
Journal:  Biochem J       Date:  1958-06       Impact factor: 3.857

5.  The immunoreaction of auto- and heteroantisera with modified human thyroglobulin.

Authors:  G B Salabè; C Davoli; S Fontana
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

6.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

7.  Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.

Authors:  D H DeHeer; T S Edgington
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

8.  Lymphocytes binding human thyroglobulin in healthy people and its relevance to tolerance for autoantigens.

Authors:  A D Bankhurst; G Torrigiani; A C Allison
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

9.  Translation of thyroglobulin 33S messenger RNA as a means of determining thyroglobulin quaternary structure.

Authors:  G Vassart; S Refetoff; H Brocas; C Dinsart; J E Dumont
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  28 in total

1.  Recognition of thyroglobulin autoantigenic epitopes by murine T and B cells.

Authors:  B R Champion; K Page; D C Rayner; R Quartey-Papafio; P G Byfield; G Henderson
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

2.  Human autoantibodies to thyroglobulin are directed towards a restricted number of human specific epitopes.

Authors:  C T Chan; P G Byfield; R L Himsworth; P Shepherd
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

3.  Antigenic determinants of human thyroglobulin differentiated using antigen fragments.

Authors:  D K Male; B R Champion; G Pryce; H Matthews; P Shepherd
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

4.  Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus.

Authors:  K Elkon; S Skelly; A Parnassa; W Moller; W Danho; H Weissbach; N Brot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Relationship between autoantibody epitopic recognition and immunoglobulin gene usage.

Authors:  J Guo; R S Mcintosh; B Czarnocka; A P Weetman; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ.

Authors:  G D Chazenbalk; S Portolano; D Russo; J S Hutchison; B Rapoport; S McLachlan
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 7.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

8.  Injection of mouse thyroglobulin and/or adult thymectomy do not break tolerance to thyroglobulin during the lupus like graft versus host disease in mice.

Authors:  F M van Rappard-van der Veen; Y M Kong; N R Rose; M Kimura; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.

Authors:  T Barkas; J A Simpson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  Interspecies cross-reactive determinants of thyroglobulin recognized by autoantibodies.

Authors:  Y Kohno; H Nakajima; O Tarutani
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.